NCT07129018 2025-08-19Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract CancerUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2 Not yet recruiting63 enrolled